NIH-funded research R21 grant

Hearing loss and lung health in World Trade Center responders

Official title: Longitudinal Assessment of Hearing Loss in World Trade Center-Exposed Responders

Funded at Albert Einstein College of Medicine · NIH-11387180 · Data updated 2026-11-12

This grant looks at how exposure to loud noise and dust from the World Trade Center disaster may be linked to hearing loss and lung problems in FDNY responders over time.

More Hearing Loss research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJuly 1, 2025
Project endJune 30, 2027
Funding year2026
Award (this year)$248,241
NIH project number5R21OH012954-02
Project IDNIH-11387180 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are World Trade Center responders with documented exposure who are willing to participate in hearing and lung function tests over time.

Less likely to help

People without significant exposure history or those unwilling to participate in longitudinal testing may not benefit.

What this research studies

The study follows World Trade Center responders to understand how their hearing changes as their lung health is affected by past exposure. It will collect data on hearing abilities and lung function to explore possible connections between respiratory issues and sensorineural hearing loss. Researchers will analyze how factors like inflammatory responses from dust exposure might influence hearing over several years. The goal is to identify patterns that could inform prevention, monitoring, and care for responders who have similar exposure histories.

Why it matters

Potential benefit: If successful, the project could improve how we monitor and protect hearing and lung health in responders and others with similar exposures.

How similar studies have gone: Prior studies have shown long-lasting hearing changes in exposed responders, suggesting this approach could reveal ongoing risks and inform care.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Goldfarb, David G — Albert Einstein College of Medicine
  • Study coordinator: Goldfarb, David G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.